Preliminary results from phase II trial of pembrolizumab with first line platinum based chemotherapy followed by maintenance pembrolizumab for patients with suboptimally cytoreduced advanced epithelial ovarian cancer
Year: 2020
Type: article
Study design: Clinical Trial
Source: Gynecologic Oncology
Institutions: Medical College of Wisconsin, Cleveland Clinic
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3034719691
